Medicine and Dentistry
Heparin
100%
Therapeutic Procedure
63%
Anticoagulation
36%
Placebo
36%
Sputum
27%
Exercise
27%
Dyspnea
27%
Lung
27%
Patient
27%
Follow up
18%
Mucus
18%
Adverse Event
18%
Pulmonary Rehabilitation
18%
Basic Protein
18%
Inpatient
18%
Coughing
18%
Diseases
9%
Morbidity
9%
Pneumonia
9%
Respiratory Disease
9%
Serositis
9%
Inhalation
9%
Respiratory Tract Inflammation
9%
Lactoferrin
9%
Beclometasone Dipropionate
9%
Polyarginine
9%
Hyperinflation
9%
Eosinophil Cationic Protein
9%
Bronchoconstriction
9%
Coagulation
9%
Thrombocyte Factor 4
9%
Lung Injury
9%
Corticosteroid
9%
Airflow
9%
Salbutamol
9%
Air Trapping
9%
Combination Therapy
9%
Mortality
9%
Health
9%
Hospital
9%
Quality of Life
9%
Assay
9%
Aptitude
9%
INIS
heparin
100%
patients
45%
lungs
45%
exercise
27%
proteins
27%
inflammation
27%
bids
27%
anticoagulants
27%
production
18%
risks
18%
capacity
18%
diseases
18%
doses
18%
comparative evaluations
9%
therapy
9%
air
9%
injuries
9%
symptoms
9%
quality of life
9%
hospitals
9%
morbidity
9%
mortality
9%
air flow
9%
medicines
9%
pneumonia
9%
trapping
9%
corticosteroids
9%
inhalation
9%
eosinophils
9%
lactoferrin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
100%
Dyspnea
27%
Adverse Event
18%
Basic Protein
18%
Coughing
18%
Preclinical Study
18%
Diseases
9%
Inflammation
9%
Morbidity
9%
Respiratory Tract Disease
9%
Lung Injury
9%
Pneumonia
9%
Salbutamol
9%
Corticosteroid
9%
Respiratory Tract Inflammation
9%
Symptom
9%
Mortality
9%
Eosinophil Cationic Protein
9%
Beclometasone Dipropionate
9%
Thrombocyte Factor 4
9%
Polyarginine
9%
Bronchoconstriction
9%
Lactoferrin
9%